No statistically significant differences were found in miR-99b, miR-135b, and Akt protein levels in CRC, PC, LVM, and normal tissues between wild-type and mutant KRAS (p > 0.05) (Table 3) (Fig. 3). This evidence concerns the gene KRAS and colorectal carcinoma.